HPV vax two-dose substitute?

Associate Professor Kristine Macartney, deputy director of government programs at the National Centre for Immunisation Research & Surveillance (NCIRS), said the Australian Technical Advisory Group on Immunisation (ATAGI) was currently looking at the efficacy and cost-effectiveness of a two-dose schedule in light of mounting international evidence that two HPV vaccine doses were just as immunogenic as three.

The news came as invited speaker Dr Marc Brisson, research chair in mathematical modelling and health economics at Laval